verified SJR 0,235 · Q3 • database Scopus / SJR indexed

United Arab Emirates · Bentham Science Publishers

workspace_premium Q3 — Medicine (miscellaneous) lock Subscription

Cardiovascular and Hematological Disorders - Drug Targets

Cardiovascular and Hematological Disorders - Drug Targets is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology with an H index of 46. It has an SJR impact factor of 0,235 and it has a best quartile of Q3. It has an SJR impact factor of 0,235.

ISSN: 1871-529X

Publisher: Bentham Science Publishers

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,235 Q3

H-index 46

Acceptance rate pie_chart

32%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR

SJR Impact

0,235

H-index

Docs (year)

Docs 3y

Total refs

1354

Cites 3y

Citable 3y

Cites/Doc 2y

0.97

Ref/Doc

54.16

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Author Index To Volume 6

Vascular C-Reactive Protein in the Pathogenesis of Coronary Artery Disease:Role of Vascular Inflammation and Oxidative Stress

Cyclooxygenase Inhibitors: Instrumental Drugs to Understand Cardiovascular Homeostasis and Arterial Thrombosis

Contemporary Management of Hypertension - How to Optimize Therapy

Complications of muscle hematomas in hemophilia

Co-existence of follicular lymphoma in the lymph node with High-grade B cell lymphoma in the bone marrow of a patient presenting with spontaneous tumor lysis syndrome

Clopidogrel-Proton Pump Inhibitor Interaction: A Primer for Clinicians

Chronic Kidney Disease and Cardiovascular Disease: A Focus on Primary Care

CD44 - a New Cardiovascular Drug Target or Merely an Innocent Bystander?

Carfilzomib: A Tale of a Heartbreaking Moment: Case Report and Concise Review of the Literature

Cardiovascular Effects of Antiretroviral Drugs: Clinical Review

Cardiovascular Disease Burden and Risk Factors Before and After Kidney Transplant

SHOW MORE ARTICLES

B-lymphocytes as Targets for Therapy in Chronic Cold Agglutinin Disease

A Case of Ischemic Stroke in Acute Promyelocytic Leukemia at Initial Presentation: Relevance of All-Trans Retinoic Acid Treatment

Atrial Fibrillation: The Emerging Role of Inflammation and Oxidative Stress

Atrial Fibrillation -New Frontiers in Anticoagulation

Atherosclerotic Coronary Heart Disease Epidemiology, Classification and Management

Atherosclerosis-Related Functions of C-Reactive Protein

Anticoagulant Therapy in Very Old Patients

An Update on Clinical and Pharmacological Aspects of Drug-Eluting Stents

Alogliptin; A Review of a New Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for the Treatment of Type 2 Diabetes Mellitus

Acute Management in Very Old Patients: Is Thrombolysis Safe?

A Stress Repair Mechanism That Maintains Vertebrate Structure During Stress

A Review on the Risk of Myocardial Infarction Associated with the NSAID Diclofenac

FAQs

Cardiovascular and Hematological Disorders - Drug Targets has an SJR of 0,235 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Cardiovascular and Hematological Disorders - Drug Targets is 32%.

Cardiovascular and Hematological Disorders - Drug Targets

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Cardiovascular and Hematological Disorders - Drug Targets?

What is the APC / publication cost?

What is the acceptance rate?